Big Pharma Split Corp Class A's stock has shown stability with a slight decline in today's trading.
Big Pharma Split Corp Class A (PRM.TO) experienced a minor pullback of 0.39% today, closing at C$15.30. Over the past week, the stock has remained unchanged, with a monthly increase of 3.73% and a year-to-date rise of 13.17%. Let's take a closer look at the recent performance and underlying factors influencing the stock.
Advertisement
Big Pharma Split Corp Class A
PRM.TO
PRM.TO
Big Pharma Split Corp Class A
WealthAwesomeMarket cap
$19.95M
Div. yield
8.05%
Div. / share
$1.24
52W high
$15.99
52W low
$10.59
1W change
+0.00%
Beta
0.73
Analyst Price Targets
Based on analyst covering PRM
Wall Street analysts forecast PRM stock price to fall 86.9% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.00
-86.9% Upside
Current Price
C$15.30
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRM's historical volatility
30-Day Vol
33.4%
Annualized
90-Day Vol
30.4%
Annualized
Trend (90d)
+48.2%
Annualized drift
90d Mean
C$18.18
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$16.20 | C$14.44 โ C$18.18 |
| 60 trading days | C$17.16 | C$14.58 โ C$20.20 |
| 90 trading days | C$18.18 | C$14.89 โ C$22.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors in Big Pharma Split Corp Class A may find comfort in the company's robust dividend yield and improving financial metrics, despite a lack of significant news this week.
C$15.30 closing price with a 9.15% dividend yield.
The stock's performance reflects a solid profit margin of 68.2% and a return on equity (ROE) of 41.5%, indicating strong financial health.
Bull case
The company's dividend yield of 9.15% is significantly higher than the average yield of 5.44% over the past four quarters. This suggests a strong return for income-focused investors.
Bear case
Analysts have a bearish outlook, with an average target of C$2.00, indicating potential downside from current levels. This could concern investors looking for growth.
Recent Performance Overview
Big Pharma Split Corp Class A has seen a stable trading week, closing at C$15.30, down 0.39% today. The stock has remained flat over the past week, with a modest increase of 3.73% in the last month. Year-to-date, it has gained 13.17%, reflecting positive momentum in the longer term.
Company News and Developments
Advertisement
No significant news has been reported for Big Pharma Split this week. However, recent headlines highlighted distribution announcements for July and June 2026, where Harvest Portfolios Group Inc. declared monthly cash distributions of $0.1031 per Class A share. This consistent dividend payment underscores the company's commitment to returning value to shareholders.
Technical Picture
The technical indicators for PRM.TO show a last close of C$15.30, which is 3.8% above the 50-day moving average of C$14.74 and 7.9% above the 200-day moving average of C$14.18. The stock has been trading within 87% of its 52-week range of C$10.59 to C$15.99. With a beta of 0.73, the stock exhibits lower volatility compared to the broader market. Notably, the trading volume today was 8,052 shares, significantly above the 20-day average volume of 2,865 shares, indicating heightened interest.
Insider Activity
Currently, there are no reported insider activities for Big Pharma Split Corp Class A. Investors may want to keep an eye on this aspect, as insider buying or selling can provide insights into management's confidence in the company's future.
Conclusion
In summary, Big Pharma Split Corp Class A closed at C$15.30, down 0.39% today. While the stock has shown resilience with a strong dividend yield and solid financial metrics, the bearish outlook from analysts may give some investors pause. As always, thorough research and consideration of individual investment goals are essential.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
